Phibro Animal Health reported $239.62M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Align Technology ALGN:US $ 973.22M 57.88M
Ani Pharmaceuticals ANIP:US $ 64.48M 3.55M
Aurora Cannabis Inc ACB:CN 50.43M 10.15M
Bristol Myers Squibb BMY:US $ 11648M 337M
Canopy Growth Corp WEED:CN C$ 111.77M 29.2M
Corcept Therapeutics CORT:US $ 93.69M 5.13M
Depomed DEPO:US $ 36.54M 3.21M
Eli Lilly And LLY:US $ 7810M 189.9M
Endo International Ordinary Shares ENDP:US $ 652.26M 137.17M
Henry Schein HSIC:US $ 3179M 151.52M
Idexx Laboratories IDXX:US $ 836.55M 35.46M
JAZZ PHA JAZZ:US $ 813.72M 83.01M
Knight Therapeutics Inc GUD:CN C$ 63.81M 5.53M
Lannett LCI:US $ 78.36M 8.15M
Merk MRK:US $ 15901M 2380M
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Pacira Pharmaceuticals PCRX:US $ 157.99M 1.2M
Phibro Animal Health PAHC:US $ 239.62M 6.91M
Prestige Brands PBH:US $ 266.94M 7.53M
Supernus Pharmaceuticals SUPN:US $ 152.51M 6.54M
Teva Pharmaceutical Industries TEVA:US $ 3661M 439M
Zoetis ZTS:US $ 1986M 19M